VentriPoint DiagnosticsVPTDF 6 Market Cap is $13.84 Mil as of Jun. 26, 2026. GuruFocus rates VPTDF with a GF Score™ of 6/100. The stock has 4 warning signs investors should review. Among 866 Medical Devices & Instruments companies, VentriPoint Diagnostics ranks worse than 81.87% on this metric.
VentriPoint Diagnostics's quarterly market cap
declined
from Jun. 2025 ($16.09 Mil) to Sep. 2025 ($11.35 Mil) but then
increased
from Sep. 2025 ($11.35 Mil) to Dec. 2025 ($17.68 Mil).
VentriPoint Diagnostics's annual market cap
declined
from Dec. 2023 ($35.79 Mil) to Dec. 2024 ($11.26 Mil) but then
increased
from Dec. 2024 ($11.26 Mil) to Dec. 2025 ($17.68 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. VentriPoint Diagnostics's Enterprise Value for Today is $15.64 Mil.
VentriPoint Diagnostics (OTCPK:VPTDF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
VentriPoint Diagnostics Market Cap Related Terms
VentriPoint Diagnostics Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, VentriPoint Diagnostics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
VentriPoint Diagnostics Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, VentriPoint Diagnostics's Market Cap distribution charts can be found below:
* The bar in red indicates where VentriPoint Diagnostics's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
VentriPoint Diagnostics's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VentriPoint Diagnostics (VPTDF) has a Market Cap of $13.84 Mil as of Jun. 26, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on VentriPoint Diagnostics and its competitors. According to the industry distribution chart, VentriPoint Diagnostics ranks #709 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 81.9%.
Is VentriPoint Diagnostics' Market Cap too high?
VentriPoint Diagnostics' current Market Cap is $13.84 Mil. The Medical Devices & Instruments industry median Market Cap is 121.29. VentriPoint Diagnostics' value of $13.84 Mil is 88.6% below this industry median. Based on the distribution chart, VentriPoint Diagnostics ranks #709 out of 866 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, VentriPoint Diagnostics has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does VentriPoint Diagnostics' Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, VentriPoint Diagnostics ranks #709 out of 866 companies for Market Cap. This places VentriPoint Diagnostics in the lower half of its industry. The industry median Market Cap is 121.29. VentriPoint Diagnostics' value of $13.84 Mil is 88.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 121.29, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. VentriPoint Diagnostics's current Market Cap of $13.84 Mil is 88.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on VentriPoint Diagnostics and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 121.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. VentriPoint Diagnostics's current Market Cap is $13.84 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VentriPoint Diagnostics stock overvalued right now?
VentriPoint Diagnostics (VPTDF) has a current Market Cap of $13.84 Mil. The current Market Cap is $13.84 Mil and 88.6% below the Medical Devices & Instruments industry median of 121.29. VentriPoint Diagnostics' overall GF Score™ is 6/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For VentriPoint Diagnostics (VPTDF), the current Market Cap is $13.84 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. Its flagship product, the Ventripoint Medical System (VMS+), transforms standard 2D and 3D echocardiography and MRI images into accurate three-dimensional heart models and volumetric measurements, enabling clinicians to assess disease severity, track progression, evaluate treatment response, and guide surgical and pharmacological decisions. Additionally, the company has developed VMS+ 3D Echo and MRI software that can be installed on any personal workstation to create a 3D model of the heart's chamber. Geographically, its products are sold in Canada and internationally.
6GF Score
Get the complete analysis for VPTDF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VPTDF has been successfully added to your 
